Philip Mazzara Sells 10,000 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total value of $1,921,600.00. Following the sale, the general counsel owned 151,573 shares in the company, valued at $29,126,267.68. This trade represents a 6.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Philip Mazzara also recently made the following trade(s):

• On Thursday, August 28th, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $188.70, for a total value of $1,887,000.00.
• On Monday, August 18th, Philip Mazzara sold 7,237 shares of Astera Labs stock. The shares were sold at an average price of $183.51, for a total value of $1,328,061.87.

Astera Labs Stock Down 4.2%

NASDAQ:ALAB opened at $200.74 on Friday. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The stock has a market capitalization of $33.37 billion, a PE ratio of 358.46, a price-to-earnings-growth ratio of 5.32 and a beta of 1.43. The stock’s 50-day moving average price is $189.83 and its 200-day moving average price is $119.14.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. During the same period last year, the firm earned $0.13 EPS. The company’s quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on ALAB shares. Deutsche Bank Aktiengesellschaft lifted their price objective on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, September 2nd. Zacks Research upgraded Astera Labs to a “strong-buy” rating in a report on Tuesday, August 12th. TD Cowen started coverage on Astera Labs in a report on Wednesday. They issued a “hold” rating and a $200.00 price objective on the stock. Susquehanna lifted their price objective on Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a report on Thursday, August 7th. Finally, Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the stock a “buy” rating in a report on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $159.83.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Oliver Lagore Vanvalin Investment Group purchased a new position in Astera Labs in the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. purchased a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $36,000. Clearstead Trust LLC raised its position in shares of Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. raised its position in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after buying an additional 194 shares during the period. Finally, Manchester Capital Management LLC raised its position in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after buying an additional 283 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.